Insider Trading History of Given Bruce D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Given Bruce D since year 2005. The trader's CIK number is 1219384. At the time of the last reporting, Given Bruce D was the CEO of Arrowhead Pharmaceuticals, Inc. . (stock ticker symbol ARWR). See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .

Note that in the past GIVEN BRUCE D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Given Bruce D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-03-01 ARWR Arrowhead Pharmaceuticals, Inc. Sale 42,500 19.99 849,574
2019-03-01 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 42,500 2.01 85,424
2019-02-25 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 42,500 2.01 85,424
2019-02-25 ARWR Arrowhead Pharmaceuticals, Inc. Sale 42,500 18.98 806,650
2019-02-19 ARWR Arrowhead Pharmaceuticals, Inc. Sale 42,500 17.98 764,150
2019-02-19 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 42,500 2.01 85,424
2019-02-15 ARWR Arrowhead Pharmaceuticals, Inc. Sale 26,250 17.67 463,837
2019-02-08 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 11,667 2.62 30,567
2019-02-08 ARWR Arrowhead Pharmaceuticals, Inc. Sale 46,167 15.34 708,201
2019-02-11 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 11,667 2.62 30,567
2019-02-12 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 42,500 2.01 85,424
2019-02-11 ARWR Arrowhead Pharmaceuticals, Inc. Sale 154,167 16.07 2,477,463
2019-02-12 ARWR Arrowhead Pharmaceuticals, Inc. Sale 42,500 17.06 725,050
2019-02-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 22,500 14.48 325,800
2019-02-01 ARWR Arrowhead Pharmaceuticals, Inc. Sale 28,500 13.85 394,725
2019-01-22 ARWR Arrowhead Pharmaceuticals, Inc. Sale 152,000 13.59 2,065,680
2019-01-23 ARWR Arrowhead Pharmaceuticals, Inc. Sale 17,500 13.15 230,125
2019-01-14 ARWR Arrowhead Pharmaceuticals, Inc. Sale 42,666 14.40 614,390
2019-01-14 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 12,666 4.41 55,857
2019-01-02 ARWR Arrowhead Pharmaceuticals, Inc. Sale 20,000 11.98 239,600
2018-03-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 20,000 6.73 134,600
2018-01-01 ARWR Arrowhead Pharmaceuticals, Inc. Sale 20,000 3.69 73,800
2005-10-11 ENCY Encysive Pharmaceuticals Inc Buy 2,000 9.73 19,454

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Given Bruce D (CEO of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.